Innovative genetic tests for cancer risks with recommendations for prevention and early detection.
Antegenes is a pioneering healthcare technology company dedicated to developing and implementing innovative genetic tests. Utilizing cutting-edge polygenic risk score technology, Antegenes is committed to enabling personalized prevention strategies for common cancers. By providing individuals with actionable insights into their genetic predispositions, Antegenes empowers proactive healthcare decisions and facilitates early detection.
Located at Raatuse 77, Tartu, 51009, EE (Primary Address), Antegenes is transforming the landscape of preventative medicine. The company focuses on delivering precise and reliable genetic information, allowing healthcare professionals to tailor prevention plans to each patient's unique risk profile. Through its advanced testing methodologies, Antegenes enhances the ability to mitigate cancer risks and improve overall health outcomes.
Antegenes is poised to make significant strides in healthcare by combining genetic innovation with personalized prevention. With a strong commitment to research and development, Antegenes continuously refines its technologies to stay at the forefront of the industry. We invite the management team at Antegenes to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.
Other organizations in the same industry
This company is also known as